These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26483897)

  • 1. The hypocretins (orexins) mediate the "phasic" components of REM sleep: A new hypothesis.
    Torterolo P; Chase MH
    Sleep Sci; 2014 Mar; 7(1):19-29. PubMed ID: 26483897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.
    Torterolo P; Sampogna S; Chase MH
    Brain Res; 2013 Jan; 1491():68-77. PubMed ID: 23122879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCH-containing neurons in the hypothalamus of the cat: searching for a role in the control of sleep and wakefulness.
    Torterolo P; Sampogna S; Morales FR; Chase MH
    Brain Res; 2006 Nov; 1119(1):101-14. PubMed ID: 17027934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation by the hypocretinergic/orexinergic neurotransmission system in sleep-wakefulness cycle states].
    del Cid-Pellitero E; Garzón M
    Rev Neurol; 2007 Oct 16-31; 45(8):482-90. PubMed ID: 17948215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.
    Naganuma F; Bandaru SS; Absi G; Mahoney CE; Scammell TE; Vetrivelan R
    Neurobiol Dis; 2018 Dec; 120():12-20. PubMed ID: 30149182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronical treatment with Fluoxetine modifies the activity of the MCHergic and hypocretinergic systems. Evidences from peptide CSF concentration and gene expression.
    Calegare BF; Costa A; Fernandes L; Dias AL; Torterolo P; Almeida VD
    Sleep Sci; 2016; 9(2):89-93. PubMed ID: 27656272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy.
    Hung CJ; Ono D; Kilduff TS; Yamanaka A
    Elife; 2020 Apr; 9():. PubMed ID: 32314734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypocretins: involvement in the regulation of sleep-wakefulness cycle and pathogenesis of narcolepsy].
    Berezińska M; Zawilska JB
    Postepy Hig Med Dosw (Online); 2007; 61():1-12. PubMed ID: 17245312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.
    Ito H; Fukatsu N; Rahaman SM; Mukai Y; Izawa S; Ono D; Kilduff TS; Yamanaka A
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2301951120. PubMed ID: 37796986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The orexin story, sleep and sleep disturbances.
    Pizza F; Barateau L; Dauvilliers Y; Plazzi G
    J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
    Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
    Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypocretins and sleep.
    de Lecea L; Sutcliffe JG
    FEBS J; 2005 Nov; 272(22):5675-88. PubMed ID: 16279933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat.
    Xi MC; Fung SJ; Yamuy J; Morales FR; Chase MH
    J Neurophysiol; 2002 Jun; 87(6):2880-8. PubMed ID: 12037191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.
    Sutcliffe JG; de Lecea L
    J Neurosci Res; 2000 Oct; 62(2):161-8. PubMed ID: 11020209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic MCH Neuron Activity Dynamics during Cataplexy of Narcolepsy.
    Sun Y; Liu M
    eNeuro; 2020; 7(2):. PubMed ID: 32303567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
    Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
    J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology of cataplexy.
    Seifinejad A; Vassalli A; Tafti M
    Sleep Med Rev; 2021 Dec; 60():101546. PubMed ID: 34607185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
    Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.